Template:Hypercalcemia treatment: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:


===Symptomatic or Severe hypercalcemia (Ca >14 mg/dL)===
===Symptomatic or Severe hypercalcemia (Ca >14 mg/dL)===
*Pts are likely dehydrated and require saline hydration as initial therapy
*Patients are likely dehydrated and require saline hydration as initial therapy


====Hydration====
====Hydration====
*Isotonic saline at 200-300 mL/hour; adjust to maintain urine output at 100-150 mL/hour
*Isotonic saline at 200-300 mL/hour; adjust to maintain urine output at 100-150 mL/hour


====Calcitonin====
====[[Calcitonin]]====
*Consider adding calcitonin 4 units/kg SC or IV q12hr in patients w/ Ca >14 mg/dL (3.5 mmol/L) who are also symptomatic (lowers Ca w/in 2-4hr)
*Consider adding calcitonin 4 units/kg SC or IV q12hr in patients w/ Ca >14 mg/dL (3.5 mmol/L) who are also symptomatic (lowers Ca w/in 2-4hr)
*Tachyphylaxis limits use long term, but is a great choice for emergent cases
*Tachyphylaxis limits use long term, but is a great choice for emergent cases
Line 19: Line 19:
Give for severe hypercalcemia due to excessive bone resorption (lowers Ca within 12-48hr)
Give for severe hypercalcemia due to excessive bone resorption (lowers Ca within 12-48hr)
*Pamidronate 90mg IV over 24 hours OR
*Pamidronate 90mg IV over 24 hours OR
*Zoledronate 4mg IV over 15 minutes
*[[Zoledronate]] 4mg IV over 15 minutes
*Caution in renal failure, though bisphosphonates have been safely used in pts with pre-existing renal failure<ref>LeGrand SB et al. Narrative Review: Furosemide for Hypercalcemia: An Unproven yet Common Practice. Ann Intern Med. 2008;149:259-263.</ref>
*Caution in renal failure, though bisphosphonates have been safely used in pts with pre-existing renal failure<ref>LeGrand SB et al. Narrative Review: Furosemide for Hypercalcemia: An Unproven yet Common Practice. Ann Intern Med. 2008;149:259-263.</ref>



Revision as of 16:52, 25 August 2019

Asymptomatic or Ca <12 mg/dL

  • Does not require immediate treatment
  • Advise to avoid factors that can aggravate hypercalcemia (thiazide diuretics, Li, volume depletion, prolonged inactivity, high Ca diet)

Mildly symptomatic Ca 12-14 mg/dL

  • May not require immediate therapy; however, an acute rise may cause symptoms necessitating treatment as described for severe hypercalcemia (see below)

Symptomatic or Severe hypercalcemia (Ca >14 mg/dL)

  • Patients are likely dehydrated and require saline hydration as initial therapy

Hydration

  • Isotonic saline at 200-300 mL/hour; adjust to maintain urine output at 100-150 mL/hour

Calcitonin

  • Consider adding calcitonin 4 units/kg SC or IV q12hr in patients w/ Ca >14 mg/dL (3.5 mmol/L) who are also symptomatic (lowers Ca w/in 2-4hr)
  • Tachyphylaxis limits use long term, but is a great choice for emergent cases

Bisphosphonates

Give for severe hypercalcemia due to excessive bone resorption (lowers Ca within 12-48hr)

  • Pamidronate 90mg IV over 24 hours OR
  • Zoledronate 4mg IV over 15 minutes
  • Caution in renal failure, though bisphosphonates have been safely used in pts with pre-existing renal failure[1]

Electrolyte Repletion

Diuresis

  • Furosemide is NOT routinely recommended
  • Only consider in patients with renal insufficiency or heart failure and volume overload

Dialysis

Consider if patient:

  • Anuric with Renal Failure
  • Failing all other therapy
  • Severe hypervolemia not amenable to diuresis
  • Serum Calcium level >18mg/dL

Corticosteroids

Decrease Ca mobilization from bone and are helpful with steroid-sensitive tumors (e.g. lymphoma, MM)

  1. LeGrand SB et al. Narrative Review: Furosemide for Hypercalcemia: An Unproven yet Common Practice. Ann Intern Med. 2008;149:259-263.